Inhalation Vaccine Development
Pharmaceutical Technology Europe
; 35(1):19-21,27, 2023.
Article
in English
| ProQuest Central | ID: covidwho-20233953
ABSTRACT
Numerous advantages to inhalation vaccines Vaccines delivered via inhalation enable targeting of the respiratory tract mucosa and generation of both humoral and cell-mediated immunity, according to Pierre A. Morgon, executive vice president. [...]inhaled vaccines delivered as liquids using nebulizers can potentially be administered with lower requirement for extensive healthcare infrastructure or as many trained healthcare personnel within an immunization centre (2). Researchers at McMaster University, for instance, have shown inhalation of a tuberculosis vaccine to be more effective than delivery via nasal sprays, because the vaccine penetrates much deeper into the airway (8). Because inhaled vaccines provide local immunity to the respiratory tract, they are seen to be ideal solutions for interrupting the spread of viruses with high transmission rates and the potential to lead to global pandemics (9). Beyond these two approaches, there are inhalation vaccines under development based on attenuated influenza virus, parainfluenza virus (PIV) 5, lentiviruses, Newcastle disease virus (NDV), and vesicular stomatitis virus (VSV);bacterium vectors, nucleic acids (messenger RNA, DNA), and protein subunits (3).
Pharmacy And Pharmacology; COVID-19 vaccines; Severe acute respiratory syndrome coronavirus 2; Regulatory approval; Immune system; Pandemics; Cytokines; Executives; Medical research; Aerosols; Viruses; Particle size; Vectors (Biology); Nose; Lungs; Drug dosages; Disease transmission; Proteins; China
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Topics:
Vaccines
Language:
English
Journal:
Pharmaceutical Technology Europe
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS